Search research articles
Contact Us
Filters
Showing results (181-190 of 301) with videos related to
Page
of 31
Sort By:
British Journal of Cancer
|
May 1, 1989
P-glycoprotein gene amplification and expression in multidrug-resistant murine P388 and B16 cell lines
G Capranico, P De Isabella, C Castelli, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1988
Potential therapeutic use of autologous human lymphocytes in metastatic melanoma: in vivo interleukin 2-activated peripheral blood lymphocytes and in vitro activated peripheral blood and tumor-infiltrating lymphocytes
G Parmiani, G Fossati, M Radrizzani, et al.
Melanoma Research
|
September 1, 1992
Expression of cytokine genes, including IL-6, in human malignant melanoma cell lines
M P Colombo, C Maccalli, S Mattei, et al.
International Journal of Cancer
|
October 15, 1990
Modulation of multidrug resistance by verapamil or mdr1 anti-sense oligodeoxynucleotide does not change the high susceptibility to lymphokine-activated killers in mdr-resistant human carcinoma (LoVo) line
L Rivoltini, M P Colombo, R Supino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 23, 2006
Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients
G Parmiani, C Castelli, L Pilla, et al.
European Journal of Immunology
|
October 28, 1997
Genetic modification of a carcinoma with the IL-4 gene increases the influx of dendritic cells relative to other cytokines
A Stoppacciaro, P Paglia, L Lombardi, et al.
International Journal of Cancer
|
March 15, 1994
Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes
S Mattei, M P Colombo, C Melani, et al.
Cancer Metastasis Reviews
|
December 1, 1988
Susceptibility of human and murine drug-resistant tumor cells to the lytic activity of rIL2-activated lymphocytes (LAK)
C Gambacorti-Passerini, L Rivoltini, M Radrizzani, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 15, 1989
Expression of retrovirus-related, cytotoxic T lymphocyte- and transplantation-defined antigens in NIH/3T3 transfectants after a single passage in nude mice
C Traversari, G Carbone, G Della Torre, et al.
Tumori
|
December 31, 1990
Local adoptive immunotherapy of advanced head and neck tumors with LAK cells and interleukin-2
M Squadrelli-Saraceno, L Rivoltini, G Cantù, et al.
Page
of 31
Search research articles
Search
Showing results (181-190 of 301) with videos related to
Sort By:
Page
of 31
British Journal of Cancer
|
May 1, 1989
P-glycoprotein gene amplification and expression in multidrug-resistant murine P388 and B16 cell lines
G Capranico, P De Isabella, C Castelli, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1988
Potential therapeutic use of autologous human lymphocytes in metastatic melanoma: in vivo interleukin 2-activated peripheral blood lymphocytes and in vitro activated peripheral blood and tumor-infiltrating lymphocytes
G Parmiani, G Fossati, M Radrizzani, et al.
Melanoma Research
|
September 1, 1992
Expression of cytokine genes, including IL-6, in human malignant melanoma cell lines
M P Colombo, C Maccalli, S Mattei, et al.
International Journal of Cancer
|
October 15, 1990
Modulation of multidrug resistance by verapamil or mdr1 anti-sense oligodeoxynucleotide does not change the high susceptibility to lymphokine-activated killers in mdr-resistant human carcinoma (LoVo) line
L Rivoltini, M P Colombo, R Supino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 23, 2006
Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients
G Parmiani, C Castelli, L Pilla, et al.
European Journal of Immunology
|
October 28, 1997
Genetic modification of a carcinoma with the IL-4 gene increases the influx of dendritic cells relative to other cytokines
A Stoppacciaro, P Paglia, L Lombardi, et al.
International Journal of Cancer
|
March 15, 1994
Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes
S Mattei, M P Colombo, C Melani, et al.
Cancer Metastasis Reviews
|
December 1, 1988
Susceptibility of human and murine drug-resistant tumor cells to the lytic activity of rIL2-activated lymphocytes (LAK)
C Gambacorti-Passerini, L Rivoltini, M Radrizzani, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 15, 1989
Expression of retrovirus-related, cytotoxic T lymphocyte- and transplantation-defined antigens in NIH/3T3 transfectants after a single passage in nude mice
C Traversari, G Carbone, G Della Torre, et al.
Tumori
|
December 31, 1990
Local adoptive immunotherapy of advanced head and neck tumors with LAK cells and interleukin-2
M Squadrelli-Saraceno, L Rivoltini, G Cantù, et al.
Page
of 31